Related Experiment Video
Updated: May 17, 2026
08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Minimally invasive surgery for valvular heart disease
Daniel G Cuadrado1, Marzia Leacche, John G Byrne
1Department of Cardiac Surgery, Vanderbilt University Medical Center, 1215 21st Avenue South, Nashville, TN, 37232, USA.
Current Treatment Options in Cardiovascular Medicine
|October 12, 2012
Summary
Minimally invasive valve surgery (MIVS) and percutaneous interventions offer reduced trauma and faster recovery for valvular heart disease. Treatment individualization is key to preserving myocardial function and achieving durable results.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Valvular heart disease causes myocardial stress, potentially leading to ventricular dysfunction.
- Traditional median sternotomy for valve disease can be invasive.
- Minimally invasive valve surgery (MIVS) and percutaneous interventions aim to reduce surgical trauma and improve recovery.
Purpose of the Study:
- To review the evolution and benefits of minimally invasive approaches for valvular heart disease.
- To compare outcomes of MIVS and percutaneous interventions with conventional surgery.
- To highlight the importance of individualized treatment for optimal patient outcomes.
Main Methods:
- Review of minimally invasive surgical techniques (MIVS) including partial sternal, parasternal, or thoracotomy incisions.
- Discussion of percutaneous catheter-based valvular interventions.
- Analysis of outcomes data comparing different approaches, particularly in high-risk patient groups.
Main Results:
- MIVS and percutaneous interventions offer reduced surgical trauma, blood utilization, and faster convalescence.
- High-risk patients show the most significant improvements in hard outcomes (mortality, morbidity) with these techniques.
- Intermediate and low-risk patients benefit from shorter hospital stays and quicker functional recovery.
Conclusions:
- Minimally invasive and percutaneous options broaden therapeutic choices for valvular heart disease, especially for high-risk individuals.
- Outcomes, including mortality and morbidity, must be comparable to conventional surgery.
- Individualizing treatment is crucial to alleviate symptoms, preserve myocardial function, and ensure durable results.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...